Skip to main content
. 2020 May 11;10(5):e035938. doi: 10.1136/bmjopen-2019-035938

Table 2.

Patient and tumour characteristics by diagnosis type: for continuous variables, figures in table represent median (range) with corresponding p-value from the Wilcoxon rank-sum test, and for categorical variables, figures in table represent n (%) with corresponding p-value from the χ2 test

Characteristic Non-incidental (n=231) Incidental (n=351) P value
Age (years) 62 (33–92) 65 (29–90) 0.04
Gender
 Female 77 (38.3) 124 (61.7)
 Male 154 (40.4) 227 (59.6) 0.69
BMI 28.3 (15.6–67.2) 27.8 (17.2–57.7) 0.38
Tumour size (path) (mm) 75 (13–240) 42 (11–170) <0.01
Tumour size (CT) (mm) 80 (16–250) 44 (10–170) <0.01
pT
 1a 25 (12.8) 170 (87.2)
 1b 48 (37.2) 81 (62.8)
 2 46 (60.5) 30 (39.5)
 3 101 (61.2) 64 (38.8)
 4 4 (100) 0 (0)
 X 0 (0) 2 (100)
 Missing 0 (0) 1 (100)
 NA* 7 (70) 3 (30) <0.01
Grade
 1 6 (66.7) 3 (33.3)
 2 56 (35.9) 100 (64.1)
 3 93 (34.6) 176 (65.4)
 4 65 (75.6) 21 (24.4)
 Missing 6 (26.1) 17 (73.9)
 NA* 5 (12.8) 34 (87.2) <0.01
Stage
 I 70 (21.6) 254 (78.4)
 II 42 (60.9) 27 (39.1)
 III 80 (58.4) 57 (41.6)
 IV 39 (78) 11 (22)
 Missing 0 (0) 2 (100) <0.01
Tumour subtype
 Clear cell 186 (40.9) 269 (59.1)
 Papillary 21 (35.6) 38 (64.4)
 Chromophobe 19 (41.3) 28 (58.7)
 Unclassified 5 (27.8) 13 (72.2)
 Other 0 (0) 3 (100) 0.62

*Not applicable (NA), patients underwent biopsy only or tumour ablation.

BMI, body mass index.